List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 899 studies with search of:   United States, North Dakota
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
Condition: Melanoma (Skin)
Interventions: Drug: everolimus;   Drug: temozolomide;   Procedure: flow cytometry;   Procedure: immunohistochemistry staining method;   Procedure: immunologic technique;   Procedure: reverse transcriptase-polymerase chain reaction
2 Active, not recruiting Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast Cancer
Condition: Breast Cancer
Interventions: Drug: CMF regimen;   Drug: capecitabine;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: fluorouracil;   Drug: methotrexate;   Procedure: adjuvant therapy
3 Recruiting Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
Conditions: Cancer-Related Problem/Condition;   Chronic Myeloproliferative Disorders;   Leukemia;   Lymphoma;   Lymphoproliferative Disorder;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases;   Pain;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: baclofen/amitriptyline/ketamine gel;   Drug: placebo
4 Active, not recruiting Capecitabine, Vinorelbine, and Trastuzumab in Treating Patients With Metastatic Breast Cancer
Condition: Breast Cancer
Interventions: Drug: capecitabine;   Drug: trastuzumab;   Drug: vinorelbine ditartrate
5 Active, not recruiting Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Condition: Breast Cancer
Interventions: Drug: carboplatin;   Drug: docetaxel;   Drug: pegfilgrastim;   Procedure: conventional surgery;   Procedure: neoadjuvant therapy
6 Recruiting Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
Condition: Breast Cancer
Interventions: Drug: bevacizumab;   Drug: cyclophosphamide;   Drug: paclitaxel;   Drug: pegylated liposomal doxorubicin hydrochloride;   Drug: placebo
7 Completed Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Conditions: Cancer-Related Problem/Condition;   Lung Cancer
Interventions: Drug: amifostine trihydrate;   Drug: cisplatin;   Drug: etoposide;   Drug: filgrastim;   Drug: paclitaxel;   Drug: topotecan hydrochloride;   Procedure: radiation therapy
8 Active, not recruiting Sunitinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Conditions: Leukemia;   Lymphoma
Interventions: Drug: sunitinib malate;   Procedure: fluorescence in situ hybridization;   Procedure: gene expression analysis;   Procedure: laboratory biomarker analysis;   Procedure: mutation analysis;   Procedure: pharmacological study
9 Active, not recruiting Fulvestrant and Bevacizumab in Treating Patients With Metastatic Breast Cancer
Condition: Breast Cancer
Interventions: Drug: bevacizumab;   Drug: fulvestrant
10 Active, not recruiting Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
Conditions: Breast Cancer;   Cancer-Related Problem/Condition
Interventions: Drug: calcium carbonate;   Drug: cholecalciferol;   Drug: risedronate sodium
11 Active, not recruiting Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
Condition: Breast Cancer
Interventions: Drug: docetaxel;   Drug: irinotecan hydrochloride
12 Recruiting Combination Chemotherapy in Treating Women With Breast Cancer
Condition: Breast Cancer
Interventions: Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: paclitaxel
13 Recruiting Sorafenib and Temsirolimus in Treating Patients With Recurrent Glioblastoma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: sorafenib tosylate;   Drug: temsirolimus
14 Active, not recruiting Monoclonal Antibody Therapy and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma
Condition: Lymphoma
Interventions: Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: epratuzumab;   Drug: prednisone;   Drug: rituximab;   Drug: vincristine sulfate
15 Active, not recruiting AZD2171 in Treating Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia
Condition: Leukemia
Interventions: Drug: cediranib maleate;   Procedure: laboratory biomarker analysis
16 Active, not recruiting Bevacizumab, Gemcitabine, and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: bevacizumab;   Drug: gemcitabine hydrochloride;   Drug: oxaliplatin
17 Recruiting Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Had Surgery for Stage II or Stage III Rectal Cancer
Condition: Colorectal Cancer
Interventions: Drug: bevacizumab;   Drug: fluorouracil;   Drug: leucovorin calcium;   Drug: oxaliplatin
18 Active, not recruiting Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer
Conditions: Colorectal Cancer;   Metastatic Cancer
Interventions: Drug: cetuximab;   Drug: fluorouracil;   Drug: leucovorin calcium;   Drug: oxaliplatin
19 Active, not recruiting Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Drug: carboplatin;   Drug: paclitaxel;   Procedure: radiation therapy
20 Active, not recruiting Sorafenib in Treating Patients With Metastatic Breast Cancer
Condition: Breast Cancer
Intervention: Drug: sorafenib tosylate

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services